DAX8.2670,5%  Dow15.3180,9%  Euro1,3393-0,0% 
ESt502.7060,2%  Nas3.4820,9%  Öl106,30,3% 
TDax960,20,1%  Nikkei13.2451,8%  Gold1.368-0,0% 
Home > Aktien > EpiCept Aktie > Nachrichten zu EpiCept

EpiCept Aktie [WKN: A0YJQP / ISIN: US2942643048]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele ProfilKnock-OutsmyHome
OrderbuchRealtime Stuttgart  InsidertradesFondsSenden
HistorischRealtime PushmyNews im ForumAnleihen 

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur EpiCept Corp. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur EpiCept Corp

03.06.13EpiCept Announces New Crolibulin Data Presented at ASCO 2013 Support Further Evaluation in Anaplastic Thyroid Cancer
22.05.13CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013
20.05.13EpiCept Reports First Quarter 2013 Operating and Financial Results
28.02.13EpiCept Reports Fourth Quarter and Full Year 2012 Operating and Financial Results
21.02.13Immune Initiates Bertilimumab Phase II Clinical Trial in Ulcerative Colitis
12.02.13EpiCept Corporation and Immune Pharmaceuticals Amend Merger Agreement
07.02.13EpiCept Corporation to Present at the 15th BIO CEO & Investor Conference
31.01.13EpiCept Reports Total Shares Outstanding
09.01.13Daniel Teper of Immune Pharmaceuticals to Present at the 6th Annual OneMedForum
14.11.12EpiCept Reports Third Quarter 2012 Operating and Financial Results
12.11.12EpiCept to Report Third Quarter 2012 Operating and Financial Results on November 14, 2012
08.11.12Immune Pharmaceuticals and EpiCept Corporation Agree to Merge
25.09.12EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants
05.09.12EpiCept Regains Rights to Azixa® from Licensee Myrexis
31.08.12EpiCept Amends Loan and Security Agreement
30.08.12EpiCept Announces Changes to Its Board of Directors
21.08.12EpiCept Announces Resignation of CEO Jack Talley
08.08.12EpiCept Reports Second Quarter 2012 Operating and Financial Results
02.08.12EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012
19.06.12EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda
12.06.12EpiCept Corporation to Present at 2012 BIO International Convention
04.06.12EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet™ CIPN Program
09.05.12EpiCept Reports First Quarter 2012 Operating and Financial Results
04.05.12EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012
30.04.12EpiCept Makes Required Swedish Regulatory Disclosure
10.04.12EpiCept’s AmiKet™ Receives Fast Track Designation from FDA
04.04.12EpiCept’s Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis
29.03.12EpiCept to Raise $1.1 Million in Registered Direct Offering
14.03.12EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event
29.02.12EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results
23.02.12EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012
09.02.12EpiCept to Raise $2 Million in Registered Direct Offering
08.02.12EpiCept to Present at the 14th Annual BIO CEO & Investor Conference
07.02.12EpiCept Files for AmiKet™ Fast Track Designation
24.01.12EpiCept Corporation Confirms Engagement of SunTrust Robinson Humphrey to Include Evaluation of Potential Sale Transactions
23.01.12EpiCept Corporation Receives Finalized FDA Guidance for AmiKet™ Phase III CIPN Program and Regulatory Strategy
09.01.12EpiCept Corporation Reduces Exercise Price and Extends Expiration Date of June 2010 Series B Warrants
09.01.12EpiCept Corporation Engages SunTrust Robinson Humphrey to Advise on Strategy to Maximize AmiKet™ Potential
05.01.12EpiCept to Present at Two Upcoming Industry Conferences
05.01.12EpiCept Corporation Appoints Alan W. Dunton, M.D. Non-Executive Chairman of the Board

Anzeige

ANZEIGE

Seite: 12345
Wie bewerten Sie diese Seite?
schlecht sehr gut
Problem mit dieser Seite?
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2013 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Knock-Outs Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon Börse App iPhone Börse App Android Börse App iPad Traderfox